275 related articles for article (PubMed ID: 31081166)
1. Evaluation of screening practices for low bone mass and prevalence of osteoporosis and fractures in people living with human immunodeficiency virus attending a sexual health clinic.
Davidson N; Sowden D
Intern Med J; 2019 Sep; 49(9):1119-1124. PubMed ID: 31081166
[TBL] [Abstract][Full Text] [Related]
2. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
Mazzotta E; Ursini T; Agostinone A; Di Nicola AD; Polilli E; Sozio F; Vadini F; Pieri A; Trave F; De Francesco V; Capasso L; Borderi M; Manzoli L; Viale P; Parruti G
AIDS Patient Care STDS; 2015 Apr; 29(4):169-80. PubMed ID: 25692868
[TBL] [Abstract][Full Text] [Related]
4. Reduced bone mineral density among HIV infected patients on anti-retroviral therapy in Blantyre, Malawi: Prevalence and associated factors.
Chisati EM; Constantinou D; Lampiao F
PLoS One; 2020; 15(1):e0227893. PubMed ID: 31935270
[TBL] [Abstract][Full Text] [Related]
5. Monitoring early developed low bone mineral density in HIV-infected patients by intact parathyroid hormone and circulating fibroblast growth factor 23.
Chen KY; Wang CH; Lin TY; Chang CY; Liu CL; Hsiao YC; Hung CC; Wang NC
J Microbiol Immunol Infect; 2019 Oct; 52(5):693-699. PubMed ID: 30293926
[TBL] [Abstract][Full Text] [Related]
6. Frailty in HIV infected people: a new risk factor for bone mineral density loss.
Bregigeon S; Galinier A; Zaegel-Faucher O; Cano CE; Obry V; Laroche H; Trijau S; Saout A; Poizot-Martin I
AIDS; 2017 Jul; 31(11):1573-1577. PubMed ID: 28426535
[TBL] [Abstract][Full Text] [Related]
7. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
Madeddu G; Spanu A; Solinas P; Babudieri S; Calia GM; Lovigu C; Mannazzu M; Nuvoli S; Piras B; Bagella P; Mura MS; Madeddu G
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4576-89. PubMed ID: 26698255
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.
Krikke M; Klomberg RCW; van der Veer E; Tesselaar K; Verhaar HJJ; Hoepelman AIM; Arends JE
Neth J Med; 2017 May; 75(4):138-144. PubMed ID: 28522769
[TBL] [Abstract][Full Text] [Related]
9. Protecting bone in long-term HIV positive patients receiving antiretrovirals.
McGinty T; Mallon P
Expert Rev Anti Infect Ther; 2016 Jun; 14(6):587-99. PubMed ID: 27189695
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.
Aydın OA; Karaosmanoglu HK; Karahasanoglu R; Tahmaz M; Nazlıcan O
Braz J Infect Dis; 2013; 17(6):707-11. PubMed ID: 24076108
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Risk Factors of Low Bone Mineral Density in HIV/AIDS Patients: A Chinese Cross-Sectional Study.
Meng W; Chen M; Song Y; Zhang H; Xie R; Zhang F
J Acquir Immune Defic Syndr; 2022 Jul; 90(3):360-368. PubMed ID: 35315797
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of undisclosed osteoporosis in patients with minimal trauma fractures: a prospective cohort study.
Scarvell JM; Van Twest MS; Stanton SF; Burski G; Smith PN
Phys Sportsmed; 2013 May; 41(2):38-43. PubMed ID: 23703516
[TBL] [Abstract][Full Text] [Related]
13. Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population.
Pinto Neto LF; Ragi-Eis S; Vieira NF; Soprani M; Neves MB; Ribeiro-Rodrigues R; Miranda AE
J Clin Densitom; 2011; 14(4):434-9. PubMed ID: 22051092
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients.
Casado JL; Bañon S; Andrés R; Perez-Elías MJ; Moreno A; Moreno S
Osteoporos Int; 2014 Mar; 25(3):1071-9. PubMed ID: 24057480
[TBL] [Abstract][Full Text] [Related]
15. Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors.
Shaiykova A; Pasquet A; Goujard C; Lion G; Durand E; Bayan T; Lachâtre M; Choisy P; Ajana F; Bourdic K; Viget N; Riff B; Quertainmont Y; Cortet B; Boufassa F; Chéret A
AIDS; 2018 Nov; 32(18):2689-2696. PubMed ID: 30234605
[TBL] [Abstract][Full Text] [Related]
16. Bone Metabolism in Men who Live with HIV Aged 50 years and Over: Impact of Infection Duration.
Caglar B; Durcan E; Karaali R; Balkan II; Kaya SY; Yavuzer H; Konukoglu D; Aygun G; Saltoglu N; Bulut IN; Sonmezoglu K; Kadioglu P; Mete B; Tabak OF
Curr HIV Res; 2024; 22(1):65-71. PubMed ID: 38279729
[TBL] [Abstract][Full Text] [Related]
17. High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy.
Escota GV; Mondy K; Bush T; Conley L; Brooks JT; Önen N; Patel P; Kojic EM; Henry K; Hammer J; Wood KC; Lichtenstein KA; Overton ET
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):59-67. PubMed ID: 26366785
[TBL] [Abstract][Full Text] [Related]
18. Do long term survivors of ewing family of tumors experience low bone mineral density and increased fracture risk?
Hobusch GM; Noebauer-Huhmann I; Krall C; Holzer G
Clin Orthop Relat Res; 2014 Nov; 472(11):3471-9. PubMed ID: 25015839
[TBL] [Abstract][Full Text] [Related]
19. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
[TBL] [Abstract][Full Text] [Related]
20. Risk of bone loss in men with multiple sclerosis.
Weinstock-Guttman B; Gallagher E; Baier M; Green L; Feichter J; Patrick K; Miller C; Wrest K; Ramanathan M
Mult Scler; 2004 Apr; 10(2):170-5. PubMed ID: 15124763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]